Characterization of the role of Facebook groups for patients who use scalp cooling therapy: a survey study
- PMID: 38748328
- PMCID: PMC11096238
- DOI: 10.1007/s00520-024-08534-y
Characterization of the role of Facebook groups for patients who use scalp cooling therapy: a survey study
Abstract
Since the emergence of scalp cooling therapy (SCT) for the prevention of chemotherapy-induced alopecia (CIA), support groups on social media platforms for interested patients have surfaced. Though there are over 20,000 active members across SCT Facebook groups, little is known about how members use this platform. A 23-question survey was posted in five scalp cooling Facebook groups, reaching 219 women. Results indicated that these Facebook groups play clear roles in providing the following: (1) a supportive community for patients, (2) instructions for SCT use, (3) advice regarding insurance coverage and reimbursement, and (4) recommendations for over-the-counter products for hair loss. Despite reported interest in hair loss products, only 5% of patients sought medical treatment from dermatologists. Due to group-specific access restrictions, private Facebook groups provide patients with a protected platform to learn more about SCT from both those with personal experience and SCT company specialists. Providers may consider recommending these online groups to interested patients during the scalp cooling counseling process. As patients with CIA express a growing interest in over-the-counter hair, eyebrow, and eyelash products, it is important for dermatologists to be aware of where their patients obtain recommendations, and further, if these recommendations have clinical evidence of efficacy.
Keywords: Alopecia; Chemotherapy-induced alopecia; Hair loss; Oncodermatology; Survivorship.
© 2024. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Similar articles
-
Efficacy of Scalp Cooling in Preventing Chemotherapy-Induced Alopecia in Breast Cancer Patients Receiving Adjuvant Docetaxel and Cyclophosphamide Chemotherapy.Clin Breast Cancer. 2015 Oct;15(5):332-4. doi: 10.1016/j.clbc.2015.01.003. Epub 2015 Jan 26. Clin Breast Cancer. 2015. PMID: 25749072
-
A Clinical and Biological Guide for Understanding Chemotherapy-Induced Alopecia and Its Prevention.Oncologist. 2018 Jan;23(1):84-96. doi: 10.1634/theoncologist.2017-0263. Epub 2017 Sep 26. Oncologist. 2018. PMID: 28951499 Free PMC article. Review.
-
Eyebrow and Eyelash Loss in Patients With Cancer.J Drugs Dermatol. 2024 May 1;23(5):327-331. doi: 10.36849/JDD.8003. J Drugs Dermatol. 2024. PMID: 38709698 Review.
-
Effect of a Scalp Cooling Device on Alopecia in Women Undergoing Chemotherapy for Breast Cancer: The SCALP Randomized Clinical Trial.JAMA. 2017 Feb 14;317(6):596-605. doi: 10.1001/jama.2016.20939. JAMA. 2017. PMID: 28196254 Clinical Trial.
-
Scalp cooling for hair loss prevention in female Japanese breast cancer patients receiving (neo)adjuvant chemotherapy.Support Care Cancer. 2021 Jan;29(1):437-443. doi: 10.1007/s00520-020-05506-w. Epub 2020 May 9. Support Care Cancer. 2021. PMID: 32388615
References
-
- Gustafson DH, McTavish FM, Stengle W, Ballard D, Hawkins R, Shaw BR, Jones E, Julèsberg K, McDowell H, Chen WC, Volrathongchai K, Landucci G. Use and impact of eHealth system by low-income women with breast cancer. J Health Commun. 2005;10(Suppl 1):195–218. doi: 10.1080/10810730500263257.M33468736P755224. - DOI - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Research Materials